Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03901222
Other study ID # 2017/309
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 31, 2019
Est. completion date August 31, 2019

Study information

Verified date March 2020
Source University of Liege
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Relatively high level athletes will undergo 2 randomized, cross-over counterbalanced sessions of bi-anodal tDCS (transcranial direct current stimulation) or sham tDCS The primary outcome is a 3D evaluation coupled with EMG (Electromyography) of their primary lower limb muscles after each session


Description:

Recruitment :

Relatively high level athletes will be recruited through social media and advertisements.

Each subject came twice to the Liege University Hospitals' Human Movement Analysis Laboratory.

After placing the different infrared emitters and placing and calibrating the surface EMG electrodes, subjects underwent 3 maximal squat jumps (without upper limb implication). They were then familiarized with the fatigue protocol (8 jumps at a 33 jumps per minute pace).

Then each subject received either bi-anodal tDCS of sham tDCS. Neither the evaluator or the subject knew which they were receiving. Immediately following tDCS, subjects underwent another warmup 3 maximal squat jumps, and then the fatigue protocol (comprised of 30 maximal jumps at a rate of 33 per minute).


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date August 31, 2019
Est. primary completion date July 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- At least 10 hours of sport a week

- Right handed and footed

Exclusion Criteria:

- One on the TSST (in high and relatively high risk sections)

- Previous neurological or orthopedic pathologies affecting limbs

Study Design


Related Conditions & MeSH terms


Intervention

Device:
tDCS
20 minutes of anodal tDCS (C3 & C4/FPZ) 2mA or sham

Locations

Country Name City State
Belgium Liege Univeristy Hospital Liege

Sponsors (1)

Lead Sponsor Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peak Height Peak height (measured by the 3D device) is measured after each of the 30 repetitions as well as after the 3 jumps before and after tDCS. Height decrease will also be looked at Changes between Prior and Immediately Following tDCS and Sham
Primary Gluteal EMG (Electromyography) recordings (% of maximal EMG value) Bilateral Gluteal EMG Changes between Prior and Immediately Following tDCS and Sham
Primary Quadriceps EMG (Electromyography) recordings (% of maximal EMG value) Bilateral Quadriceps EMG triceps surae will be measured Changes between Prior and Immediately Following tDCS and Sham
Primary Triceps EMG (Electromyography) recordings (% of maximal EMG value) Bilateral Triceps Surae EMG Changes between Prior and Immediately Following tDCS and Sham
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1